Correlation Between Pliant Therapeutics and Lipocine
Can any of the company-specific risk be diversified away by investing in both Pliant Therapeutics and Lipocine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pliant Therapeutics and Lipocine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pliant Therapeutics and Lipocine, you can compare the effects of market volatilities on Pliant Therapeutics and Lipocine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pliant Therapeutics with a short position of Lipocine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pliant Therapeutics and Lipocine.
Diversification Opportunities for Pliant Therapeutics and Lipocine
0.63 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Pliant and Lipocine is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Pliant Therapeutics and Lipocine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lipocine and Pliant Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pliant Therapeutics are associated (or correlated) with Lipocine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lipocine has no effect on the direction of Pliant Therapeutics i.e., Pliant Therapeutics and Lipocine go up and down completely randomly.
Pair Corralation between Pliant Therapeutics and Lipocine
Given the investment horizon of 90 days Pliant Therapeutics is expected to generate 1.07 times more return on investment than Lipocine. However, Pliant Therapeutics is 1.07 times more volatile than Lipocine. It trades about -0.03 of its potential returns per unit of risk. Lipocine is currently generating about -0.33 per unit of risk. If you would invest 1,261 in Pliant Therapeutics on November 9, 2024 and sell it today you would lose (66.00) from holding Pliant Therapeutics or give up 5.23% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pliant Therapeutics vs. Lipocine
Performance |
| Timeline |
| Pliant Therapeutics |
| Lipocine |
Pliant Therapeutics and Lipocine Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pliant Therapeutics and Lipocine
The main advantage of trading using opposite Pliant Therapeutics and Lipocine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pliant Therapeutics position performs unexpectedly, Lipocine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipocine will offset losses from the drop in Lipocine's long position.| Pliant Therapeutics vs. Relay Therapeutics | Pliant Therapeutics vs. Stoke Therapeutics | Pliant Therapeutics vs. Black Diamond Therapeutics | Pliant Therapeutics vs. Arvinas |
| Lipocine vs. Reviva Pharmaceuticals Holdings | Lipocine vs. ZyVersa Therapeutics | Lipocine vs. Unicycive Therapeutics | Lipocine vs. Checkpoint Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |